Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and lactose

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with lactose in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Studies
(lactose)		Trials
(lactose)		Recent Studies (post-2010) (lactose)
6383124312,2014463,106

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Du, J; Gong, Q; Gu, Z; Li, Z; Luo, K; Pan, D; Tian, X; Wang, X; Xiao, X; Zhang, H; Zhang, X1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and lactose

ArticleYear
Lactose-modified enzyme-sensitive branched polymers as a nanoscale liver cancer-targeting MRI contrast agent.
    Nanoscale, 2023, Jan-05, Volume: 15, Issue:2

    Topics: Animals; Contrast Media; Lactose; Liver Neoplasms; Macromolecular Substances; Magnetic Resonance Imaging; Mice; Polymers

2023